MXPA06006685A - Uso de gaboxadol para tratar el insomnio. - Google Patents

Uso de gaboxadol para tratar el insomnio.

Info

Publication number
MXPA06006685A
MXPA06006685A MXPA06006685A MXPA06006685A MXPA06006685A MX PA06006685 A MXPA06006685 A MX PA06006685A MX PA06006685 A MXPA06006685 A MX PA06006685A MX PA06006685 A MXPA06006685 A MX PA06006685A MX PA06006685 A MXPA06006685 A MX PA06006685A
Authority
MX
Mexico
Prior art keywords
gaboxadol
insomnia
treatment
patient
oral dosage
Prior art date
Application number
MXPA06006685A
Other languages
English (en)
Spanish (es)
Inventor
Jona Lundahl
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA06006685(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MXPA06006685A publication Critical patent/MXPA06006685A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
MXPA06006685A 2003-12-18 2004-12-14 Uso de gaboxadol para tratar el insomnio. MXPA06006685A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
MXPA06006685A true MXPA06006685A (es) 2006-08-23

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06006685A MXPA06006685A (es) 2003-12-18 2004-12-14 Uso de gaboxadol para tratar el insomnio.

Country Status (17)

Country Link
EP (1) EP1720547A1 (ru)
JP (1) JP2007515415A (ru)
KR (1) KR20060103335A (ru)
CN (1) CN1893942A (ru)
AR (1) AR047154A1 (ru)
AU (1) AU2004298313A1 (ru)
BR (1) BRPI0415893A (ru)
CA (1) CA2550610A1 (ru)
EA (1) EA200600989A1 (ru)
IL (1) IL176239A0 (ru)
IS (1) IS8390A (ru)
MX (1) MXPA06006685A (ru)
NO (1) NO20063320L (ru)
SG (1) SG133601A1 (ru)
TW (1) TW200528098A (ru)
WO (1) WO2005058313A1 (ru)
ZA (1) ZA200602762B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
EP1906953A4 (en) * 2005-04-29 2009-05-20 Lundbeck & Co As H FORMS OF ACID SALTS AND BASIC SALTS OF GABOXADOL
WO2019055369A1 (en) * 2017-09-12 2019-03-21 Ovid Therapeutics Inc. USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
AU2019405489A1 (en) 2018-12-17 2021-06-10 Ovid Therapeutics Inc. Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
WO2021127308A1 (en) 2019-12-18 2021-06-24 Ovid Therapeutics Inc. GABOXADOL FOR THERAPEUTIC TREATMENT OF 1p36 DELETION SYNDROME

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
JP2004530695A (ja) * 2001-05-21 2004-10-07 ハー・ルンドベック・アクチエゼルスカベット ガボキサドールの顆粒状調合物

Also Published As

Publication number Publication date
AR047154A1 (es) 2006-01-11
TW200528098A (en) 2005-09-01
BRPI0415893A (pt) 2007-01-09
ZA200602762B (en) 2007-06-27
CA2550610A1 (en) 2005-06-30
SG133601A1 (en) 2007-07-30
CN1893942A (zh) 2007-01-10
WO2005058313A1 (en) 2005-06-30
AU2004298313A1 (en) 2005-06-30
KR20060103335A (ko) 2006-09-28
JP2007515415A (ja) 2007-06-14
EP1720547A1 (en) 2006-11-15
IL176239A0 (en) 2006-10-05
IS8390A (is) 2006-03-30
NO20063320L (no) 2006-07-18
EA200600989A1 (ru) 2006-10-27

Similar Documents

Publication Publication Date Title
US9700548B2 (en) Antihistamines combined with dietary supplements for improved health
MXPA05002827A (es) Formulaciones farmaceuticas de modafinil.
JP2008519847A (ja) 運動障害の治療方法
JPH06508836A (ja) 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
JP2021080276A (ja) デクスメデトミジン製剤を使用する睡眠障害の予防または治療
KR20090120423A (ko) 조루증 치료를 위한 경구용 의약 조성물
RU2464023C2 (ru) Лекарственное средство для лечения фибромиалгии
US20050137222A1 (en) Treatment of insomnia in human patients
MXPA06006685A (es) Uso de gaboxadol para tratar el insomnio.
NO309965B1 (no) Oralt farmasøytisk antihostepreparat
MXPA06015196A (es) Tratamiento del dolor neuropatico, la fibromialgia o la artritis reumatoide.
JP2007515415A6 (ja) 不眠症の治療にガボクサドールを使用する方法
TW202308653A (zh) 以神經活性類固醇進行治療的方法
JPH0196131A (ja) 睡眠障害および鬱病を治療するためのある種の化合物の使用
JP2001526217A (ja) 血管性頭痛に対する局所麻酔薬の新規な使用
JPH0149124B2 (ru)
JP2022554231A (ja) 過敏性腸症候群の予防又は治療のための医薬的組み合わせ
JP4135977B2 (ja) β−受容体遮断薬とオピオイドとの新規な組合せ物
CN112691102A (zh) 黄芩素在防治帕金森病/帕金森综合征抑郁症状中的应用
EP1611901B1 (en) Preventive or remedy for teeth grinding
US20190008188A1 (en) Antihistamines Combined with Dietary Supplements for Improved Health
JP2022529290A (ja) 呼吸性不整脈を処置するための方法および組成物
US20070054940A1 (en) Remedy for down's syndrome
EP4277614A1 (en) Compositions and methods for inducing defecation
TW201919597A (zh) 利用新斯的明（neostigmine）及nk-1拮抗劑治療重症肌無力之醫藥組合物及方法